Viral Hepatitis: Chronic Hepatitis C

This book presents up-to-date, practically oriented information on major topics in chronic hepatitis C. The coverage encompasses epidemiology; diagnosis, including molecular methods; treatment and challenges; and the management of co-infections. Readers w

  • PDF / 3,749,347 Bytes
  • 220 Pages / 439.42 x 666.14 pts Page_size
  • 26 Downloads / 251 Views

DOWNLOAD

REPORT


123

Viral Hepatitis: Chronic Hepatitis C

Resat Ozaras  •  Dominique Salmon-Ceron Editors

Viral Hepatitis: Chronic Hepatitis C

Editors Resat Ozaras ESCMID Study Group for Viral Hepatitis (ESGVH) Istanbul Turkey

Dominique Salmon-Ceron Infectious Diseases Department Hôtel Dieu Hospital University of Paris Paris France

ISBN 978-3-030-03756-7    ISBN 978-3-030-03757-4 (eBook) https://doi.org/10.1007/978-3-030-03757-4 Library of Congress Control Number: 2019930043 © Springer Nature Switzerland AG 2019 This work is subject to copyright. All rights are reserved by the Publisher, whether the whole or part of the material is concerned, specifically the rights of translation, reprinting, reuse of illustrations, recitation, broadcasting, reproduction on microfilms or in any other physical way, and transmission or information storage and retrieval, electronic adaptation, computer software, or by similar or dissimilar methodology now known or hereafter developed. The use of general descriptive names, registered names, trademarks, service marks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant protective laws and regulations and therefore free for general use. The publisher, the authors, and the editors are safe to assume that the advice and information in this book are believed to be true and accurate at the date of publication. Neither the publisher nor the authors or the editors give a warranty, express or implied, with respect to the material contained herein or for any errors or omissions that may have been made. The publisher remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. This Springer imprint is published by the registered company Springer Nature Switzerland AG The registered company address is: Gewerbestrasse 11, 6330 Cham, Switzerland

Dr. Resat Ozaras dedicates this book to Nihal, Emre, and Omer and Dr. Dominique Salmon-Ceron dedicates this book to Pierre Guillaume, Alexandre, Ariane, and Vincent

Foreword

Hepatology is a rapidly evolving field that will continue to grow and maintain excitement over the next decades. In the treatment of hepatitis C we have witnessed a revolution, making a very hard to cure disease to an infection which can be successfully treated in almost all patients without major side effects. Some subpopulations still require special attention, e.g., HCV/HIV-coinfected patients, patients with extrahepatic manifestations, patients who previously failed an antiviral regimen, patients with decompensated cirrhosis, those after organ transplantation, and last but certainly not least patients who inject drugs (PWIDs). In the last decade, HCV treatment guidelines had to be revised on at least an annual basis. Now, with the development of pangenotypic therapies, management and treatment guidelines have consolidated. With the easy algorithms the challenges have moved away from treatment optimization to issues of screening, case finding, linkage to care and elimin